Live Breaking News & Updates on Langfj Hematol

Stay updated with breaking news from Langfj hematol. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Novartis UK: First STAMP (specifically targeting the abl myristoyl pocket) inhibitor for treatment for chronic myeloid leukaemia (CML), Scemblix? (asciminib) receives NICE final draft recommendation in Great Britain

Asciminib final draft recommended by the National Institute for Health and Care Excellence (NICE) for use for treatment of adult patients with Philadelphia chromosome-positive chronic myeloid ....

United Kingdom , City Of , United States , Great Britain , Dragana Milojkovic , Heather Moses , Langfj Hematol , David Fitzgerald , Novartis United Kingdom Press Office , Health And Care Excellence , National Institute For Health , Imperial College London , Cancer Research United Kingdom , Prnewswire Novartis Pharmaceuticals United Kingdom , Department Of Immunology , National Institute , Care Excellence , Pharmaceuticals United Kingdom , Final Appraisal Determination , Chronic Myeloid Malignancies , Imperial College , Novartis United , Novartis Commitment , Institute For Health And Care Excellence , Adv Hematol , Research United Kingdom ,